19.31 0.43 (2.28%)
318.4K XNYS Volume
XNYS 24 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 54,353 (1%) | 0% | 19.6 | 62,483 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 88,646 (1%) | 0% | 19.6 | 62,483 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 50,309 (1%) | 0% | 19.6 | 62,483 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 43,150 (0%) | 0% | 19.6 | 62,483 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 19,446 (0%) | 0% | 19.6 | 62,483 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 49,802 | 609,997 (12%) | 1% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,147 | 624,547 (12%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 19,597 | 590,400 (11%) | 0% | 20.3 | 397,035 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 12,078 | 184,070 (3%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 2,940 | 181,130 (3%) | 0% | 20.3 | 59,564 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 10,366 | 191,496 (3%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 17,078 | 172,357 (3%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 4,158 | 168,199 (3%) | 0% | 20.3 | 84,241 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 16,090 | 184,289 (3%) | 0% | 0 | Common Stock | |
Lisa M. Vorakoun | SVP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 9,283 | 46,009 (0%) | 0% | 0 | Common Stock | |
Lisa M. Vorakoun | SVP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.26 per share. | 11 Feb 2025 | 1,615 | 36,726 (0%) | 0% | 20.3 | 32,720 | Common Stock |
Lisa M. Vorakoun | SVP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 4,122 | 38,341 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.72 per share. | 28 Jan 2025 | 10,359 | 560,195 (11%) | 0% | 19.7 | 204,279 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.72 per share. | 28 Jan 2025 | 2,840 | 171,992 (3%) | 0% | 19.7 | 56,005 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.72 per share. | 28 Jan 2025 | 3,264 | 155,279 (3%) | 0% | 19.7 | 64,366 | Common Stock |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.72 per share. | 28 Jan 2025 | 1,755 | 34,219 (0%) | 0% | 19.7 | 34,609 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 625 | 51,168 (1%) | 0% | 20.0 | 12,488 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 1,000 | 85,461 (1%) | 0% | 20.0 | 19,981 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 1,047 | 47,124 (0%) | 0% | 20.0 | 20,920 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 954 | 39,965 (0%) | 0% | 20.0 | 19,061 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 813 | 16,261 (0%) | 0% | 20.0 | 16,244 | Common Stock |
Earl Daniel Smith | SVP, GEN COUNSEL & CORP SECRET | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Nov 2024 | 836 | 174,832 (3%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 20.71 per share. | 11 Nov 2024 | 29,488 | 570,554 (11%) | 0% | 20.7 | 610,579 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.22 per share. | 01 Oct 2024 | 650 | 50,405 (1%) | 0% | 19.2 | 12,495 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 19.22 per share. | 01 Oct 2024 | 1,040 | 84,461 (1%) | 0% | 19.2 | 19,992 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 19.22 per share. | 01 Oct 2024 | 1,089 | 46,077 (0%) | 0% | 19.2 | 20,934 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 19.22 per share. | 01 Oct 2024 | 991 | 39,011 (0%) | 0% | 19.2 | 19,050 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 19.22 per share. | 01 Oct 2024 | 845 | 15,448 (0%) | 0% | 19.2 | 16,244 | Common Stock |
Christopher W. Haga | Director | Sale of securities on an exchange or to another person at price $ 19.45 per share. | 09 Sep 2024 | 750 | 0 (0%) | 0% | 19.5 | 14,588 | Common Stock |
Christopher W. Haga | Director | Sale of securities on an exchange or to another person at price $ 19.46 per share. | 09 Sep 2024 | 2,250 | 750 (0%) | 0% | 19.5 | 43,774 | Common Stock |
Christopher W. Haga | Director | Sale of securities on an exchange or to another person at price $ 19.20 per share. | 29 Aug 2024 | 1,000 | 2,000 (0%) | 0% | 19.2 | 19,195 | Common Stock |
Christopher W. Haga | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 29 Aug 2024 | 1,500 | 0 (0%) | 0% | 19.2 | 28,785 | Common Stock |
Christopher W. Haga | Director | Sale of securities on an exchange or to another person at price $ 19.19 per share. | 29 Aug 2024 | 500 | 1,500 (0%) | 0% | 19.2 | 9,593 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 17.56 per share. | 01 Jul 2024 | 712 | 49,616 (1%) | 0% | 17.6 | 12,500 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 17.56 per share. | 01 Jul 2024 | 1,139 | 83,421 (1%) | 0% | 17.6 | 19,996 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 17.56 per share. | 01 Jul 2024 | 1,192 | 44,988 (0%) | 0% | 17.6 | 20,926 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 17.56 per share. | 01 Jul 2024 | 1,085 | 38,020 (0%) | 0% | 17.6 | 19,048 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 17.56 per share. | 01 Jul 2024 | 925 | 14,603 (0%) | 0% | 17.6 | 16,239 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 16.86 per share. | 01 Apr 2024 | 741 | 48,756 (0%) | 0% | 16.9 | 12,495 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 16.86 per share. | 01 Apr 2024 | 1,186 | 82,282 (1%) | 0% | 16.9 | 19,999 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 16.86 per share. | 01 Apr 2024 | 1,241 | 43,796 (0%) | 0% | 16.9 | 20,926 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 16.86 per share. | 01 Apr 2024 | 1,130 | 36,935 (0%) | 0% | 16.9 | 19,055 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 16.86 per share. | 01 Apr 2024 | 963 | 13,678 (0%) | 0% | 16.9 | 16,239 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 10,899 | 175,668 (3%) | 0% | 0 | Common Stock | |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 6,883 | 35,974 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 16.71 per share. | 14 Feb 2024 | 3,740 | 47,865 (0%) | 0% | 16.7 | 62,492 | Common Stock |
M. Partridge Matthew | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,532 | 123,802 (2%) | 0% | 0 | Common Stock | |
P. John Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 29,525 | 600,042 (12%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 16.71 per share. | 14 Feb 2024 | 3,740 | 35,805 (0%) | 0% | 16.7 | 62,492 | Common Stock |
J. Christopher Drew | Director | Grant, award, or other acquisition of securities at price $ 16.71 per share. | 14 Feb 2024 | 3,740 | 12,715 (0%) | 0% | 16.7 | 62,492 | Common Stock |
Robert Steven Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 14,532 | 158,543 (3%) | 0% | 0 | Common Stock | |
Haga Christopher W. | Director | Grant, award, or other acquisition of securities at price $ 16.71 per share. | 14 Feb 2024 | 3,740 | 42,555 (0%) | 0% | 16.7 | 62,492 | Common Stock |
R. Brokaw George | Director | Grant, award, or other acquisition of securities at price $ 16.71 per share. | 14 Feb 2024 | 3,740 | 81,096 (1%) | 0% | 16.7 | 62,492 | Common Stock |
Robert Greathouse Steven | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.84 per share. | 26 Jan 2024 | 2,801 | 144,011 (2%) | 0% | 16.8 | 47,169 | Common Stock |
M. Vorakoun Lisa | VP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.84 per share. | 26 Jan 2024 | 1,412 | 29,091 (0%) | 0% | 16.8 | 23,778 | Common Stock |
John Albright P. | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.84 per share. | 26 Jan 2024 | 10,227 | 570,517 (11%) | 0% | 16.8 | 172,223 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.84 per share. | 26 Jan 2024 | 3,786 | 164,769 (3%) | 0% | 16.8 | 63,756 | Common Stock |
Partridge Matthew M. | SR. VP, CFO & TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.84 per share. | 26 Jan 2024 | 4,527 | 109,270 (2%) | 0% | 16.8 | 76,235 | Common Stock |
P. John Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 10 Jan 2024 | 25,674 | 580,744 (11%) | 0% | 17.1 | 438,512 | Common Stock |
Partridge M. Matthew | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 22,005 | 122,912 (2%) | 0% | 0 | Common Stock | |
M. Matthew Partridge | SR. VP, CFO & TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 10 Jan 2024 | 9,115 | 113,797 (2%) | 0% | 17.1 | 155,684 | Common Stock |
Vorakoun Lisa M. | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 5,171 | 32,811 (0%) | 0% | 0 | Common Stock | |
Robert Greathouse Steven | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 10 Jan 2024 | 5,814 | 146,812 (2%) | 0% | 17.1 | 99,303 | Common Stock |
Vorakoun Lisa M. | VP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 10 Jan 2024 | 2,308 | 30,503 (0%) | 0% | 17.1 | 39,421 | Common Stock |
Smith Daniel Earl | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 15,561 | 175,147 (3%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 22,005 | 152,626 (3%) | 0% | 0 | Common Stock | |
P. Albright John | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 64,166 | 606,418 (12%) | 1% | 0 | Common Stock | |
Earl Daniel Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.08 per share. | 10 Jan 2024 | 6,592 | 168,555 (3%) | 0% | 17.1 | 112,591 | Common Stock |
Christopher Haga W. | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 02 Jan 2024 | 903 | 38,815 (0%) | 0% | 17.3 | 15,622 | Common Stock |
Drew J. Christopher | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 02 Jan 2024 | 722 | 8,975 (0%) | 0% | 17.3 | 12,491 | Common Stock |
Blakeslee Gable R. | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 02 Jan 2024 | 830 | 32,065 (0%) | 0% | 17.3 | 14,359 | Common Stock |
Franklin M. Laura | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 02 Jan 2024 | 578 | 44,125 (0%) | 0% | 17.3 | 9,999 | Common Stock |
R. Brokaw George | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 02 Jan 2024 | 867 | 77,356 (1%) | 0% | 17.3 | 14,999 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 02 Oct 2023 | 599 | 43,119 (0%) | 0% | 16.7 | 9,994 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 16.69 per share. | 02 Oct 2023 | 899 | 76,489 (1%) | 0% | 16.7 | 15,000 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 02 Oct 2023 | 936 | 37,912 (0%) | 0% | 16.7 | 15,617 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 16.69 per share. | 02 Oct 2023 | 861 | 31,235 (0%) | 0% | 16.7 | 14,366 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 02 Oct 2023 | 749 | 8,253 (0%) | 0% | 16.7 | 12,497 | Common Stock |
Franklin Laura M. | Director | Grant, award, or other acquisition of securities at price $ 16.68 per share. | 02 Oct 2023 | 599 | 43,406 (0%) | 0% | 16.7 | 9,994 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 16.03 per share. | 25 Sep 2023 | 9,000 | 542,252 (11%) | 0% | 16.0 | 144,301 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 596 | 42,520 (0%) | 0% | 16.8 | 9,989 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 894 | 75,590 (1%) | 0% | 16.8 | 14,984 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 932 | 36,976 (0%) | 0% | 16.8 | 15,621 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 857 | 30,374 (0%) | 0% | 16.8 | 14,364 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 745 | 7,504 (0%) | 0% | 16.8 | 12,487 | Common Stock |
Franklin Laura M. | Director | Grant, award, or other acquisition of securities at price $ 16.76 per share. | 03 Jul 2023 | 596 | 42,659 (0%) | 0% | 16.8 | 9,989 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 16.66 per share. | 03 Apr 2023 | 600 | 41,924 (0%) | 0% | 16.7 | 9,997 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 16.66 per share. | 03 Apr 2023 | 900 | 74,696 (1%) | 0% | 16.7 | 14,995 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 16.66 per share. | 03 Apr 2023 | 937 | 36,044 (0%) | 0% | 16.7 | 15,612 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 16.66 per share. | 03 Apr 2023 | 862 | 29,517 (0%) | 0% | 16.7 | 14,362 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 16.66 per share. | 03 Apr 2023 | 750 | 6,759 (0%) | 0% | 16.7 | 12,496 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 16.30 per share. | 10 Mar 2023 | 355 | 355 (0%) | 0% | 16.3 | 5,787 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 16.62 per share. | 10 Mar 2023 | 1,400 | 533,252 (10%) | 0% | 16.6 | 23,263 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 16.60 per share. | 10 Mar 2023 | 1,000 | 157,744 (3%) | 0% | 16.6 | 16,600 | Common Stock |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Purchase of securities on an exchange or from another person at price $ 16.75 per share. | 10 Mar 2023 | 2,500 | 100,907 (2%) | 0% | 16.8 | 41,875 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 17.01 per share. | 08 Mar 2023 | 6,200 | 531,852 (10%) | 0% | 17.0 | 105,443 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Purchase of securities on an exchange or from another person at price $ 16.92 per share. | 08 Mar 2023 | 1,182 | 130,621 (2%) | 0% | 16.9 | 19,999 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 17.55 per share. | 28 Feb 2023 | 890 | 3,000 (0%) | 0% | 17.6 | 15,620 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 17.89 per share. | 28 Feb 2023 | 2,000 | 156,744 (3%) | 0% | 17.9 | 35,784 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 17.39 per share. | 28 Feb 2023 | 1,000 | 2,110 (0%) | 0% | 17.4 | 17,390 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 25,737 | 525,652 (10%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.17 per share. | 16 Feb 2023 | 1,826 | 41,186 (0%) | 0% | 19.2 | 35,002 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 19.17 per share. | 16 Feb 2023 | 1,826 | 73,796 (1%) | 0% | 19.2 | 35,002 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 19.17 per share. | 16 Feb 2023 | 1,826 | 35,107 (0%) | 0% | 19.2 | 35,002 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 13,413 | 154,744 (3%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 12,667 | 98,407 (1%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 12,667 | 129,293 (2%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 19.17 per share. | 16 Feb 2023 | 1,826 | 28,655 (0%) | 0% | 19.2 | 35,002 | Common Stock |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 5,778 | 27,548 (0%) | 0% | 0 | Common Stock | |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 19.17 per share. | 16 Feb 2023 | 1,826 | 6,009 (0%) | 0% | 19.2 | 35,002 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.29 per share. | 27 Jan 2023 | 10,140 | 499,915 (10%) | 0% | 19.3 | 195,601 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.29 per share. | 27 Jan 2023 | 1,848 | 141,460 (2%) | 0% | 19.3 | 35,648 | Common Stock |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.29 per share. | 27 Jan 2023 | 5,835 | 85,740 (1%) | 0% | 19.3 | 112,557 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.29 per share. | 27 Jan 2023 | 2,494 | 116,772 (2%) | 0% | 19.3 | 48,109 | Common Stock |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.29 per share. | 27 Jan 2023 | 1,307 | 21,862 (0%) | 0% | 19.3 | 25,212 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.52 per share. | 10 Jan 2023 | 15,677 | 510,055 (10%) | 0% | 18.5 | 290,338 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 56,408 | 525,732 (10%) | 1% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.52 per share. | 10 Jan 2023 | 3,553 | 143,308 (2%) | 0% | 18.5 | 65,802 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 13,473 | 146,861 (2%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 17,336 | 96,024 (1%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.52 per share. | 10 Jan 2023 | 4,449 | 91,575 (1%) | 0% | 18.5 | 82,395 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.52 per share. | 10 Jan 2023 | 4,208 | 119,266 (2%) | 0% | 18.5 | 77,932 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 16,335 | 123,474 (2%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 18.56 per share. | 03 Jan 2023 | 538 | 39,360 (0%) | 0% | 18.6 | 9,985 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 18.56 per share. | 03 Jan 2023 | 808 | 71,970 (1%) | 0% | 18.6 | 14,996 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 18.56 per share. | 03 Jan 2023 | 841 | 33,281 (0%) | 0% | 18.6 | 15,609 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 18.56 per share. | 03 Jan 2023 | 774 | 26,829 (0%) | 0% | 18.6 | 14,365 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 18.56 per share. | 03 Jan 2023 | 673 | 4,183 (0%) | 0% | 18.6 | 12,491 | Common Stock |
Laura M. Franklin | Director | Other type of transaction at price $ 19.00 per share. | 05 Dec 2022 | 6,315 | 38,697 (0%) | 0% | 19 | 119,985 | Common Stock |
George R. Brokaw | Director | Other type of transaction at price $ 19.00 per share. | 05 Dec 2022 | 10,000 | 71,162 (1%) | 0% | 19 | 190,000 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.84 per share. | 01 Oct 2022 | 503 | 32,382 (0%) | 0% | 19.8 | 9,982 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 19.85 per share. | 01 Oct 2022 | 755 | 61,162 (1%) | 0% | 19.8 | 14,983 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 19.84 per share. | 01 Oct 2022 | 787 | 32,440 (0%) | 0% | 19.8 | 15,618 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 19.84 per share. | 01 Oct 2022 | 724 | 26,055 (0%) | 0% | 19.8 | 14,367 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 19.84 per share. | 01 Oct 2022 | 629 | 3,510 (0%) | 0% | 19.8 | 12,482 | Common Stock |
R. Blakeslee Gable | Director | Purchase of securities on an exchange or from another person at price $ 21.50 per share. | 02 Aug 2022 | 1,245 | 25,331 (0%) | 0% | 21.5 | 26,768 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 20.42 per share. | 01 Jul 2022 | 489 | 31,653 (0%) | 0% | 20.4 | 9,983 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 20.41 per share. | 01 Jul 2022 | 734 | 60,407 (1%) | 0% | 20.4 | 14,984 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 20.41 per share. | 01 Jul 2022 | 765 | 11,061 (0%) | 0% | 20.4 | 15,617 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 18.75 per share. | 01 Jul 2022 | 500 | 130,991 (2%) | 0% | 18.7 | 9,373 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 18.87 per share. | 01 Jul 2022 | 500 | 130,491 (2%) | 0% | 18.9 | 9,434 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 9,000 | 129,991 (2%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Purchase of securities on an exchange or from another person at price $ 18.92 per share. | 01 Jul 2022 | 1,300 | 78,688 (1%) | 0% | 18.9 | 24,596 | Common Stock |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 21,000 | 77,388 (1%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 21,000 | 107,139 (2%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 20.41 per share. | 01 Jul 2022 | 704 | 24,086 (0%) | 0% | 20.4 | 14,372 | Common Stock |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.52 per share. | 01 Jul 2022 | 1,373 | 23,169 (0%) | 0% | 18.5 | 25,428 | Common Stock |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 9,000 | 19,911 (0%) | 0% | 0 | Common Stock | |
Lisa M. Vorakoun | VP & CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,631 | 24,542 (0%) | 0% | 0 | Common Stock | |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 20.41 per share. | 01 Jul 2022 | 640 | 2,881 (0%) | 0% | 20.4 | 13,065 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 60.40 per share. | 13 Jun 2022 | 1,000 | 19,891 (0%) | 0% | 60.4 | 60,400 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 07 Jun 2022 | 9,000 | 46,291 (0%) | 0% | 39.9 | 358,830 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.97 per share. | 07 Jun 2022 | 6,306 | 39,985 (0%) | 0% | 66.0 | 416,007 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 9,000 | 0 | - | - | Employee Stock Option | |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 194 | 8,999 (0%) | 0% | 64.4 | 12,487 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 155 | 10,357 (0%) | 0% | 64.4 | 9,977 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 233 | 18,891 (0%) | 0% | 64.4 | 14,998 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 242 | 10,296 (0%) | 0% | 64.4 | 15,577 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 223 | 7,794 (0%) | 0% | 64.4 | 14,354 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 64.37 per share. | 01 Apr 2022 | 165 | 747 (0%) | 0% | 64.4 | 10,621 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 8,805 (0%) | 0% | 60.0 | 34,942 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 7,609 | 156,441 (3%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 10,202 (0%) | 0% | 60.0 | 34,942 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 18,658 (0%) | 0% | 60.0 | 34,942 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 10,054 (0%) | 0% | 60.0 | 34,942 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,251 | 37,030 (0%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,183 | 18,796 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,183 | 28,713 (0%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 7,571 (0%) | 0% | 60.0 | 34,942 | Common Stock |
Christopher J. Drew | Director | Grant, award, or other acquisition of securities at price $ 60.04 per share. | 17 Feb 2022 | 582 | 582 (0%) | 0% | 60.0 | 34,942 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.80 per share. | 27 Jan 2022 | 5,832 | 152,421 (3%) | 0% | 57.8 | 337,090 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.95 per share. | 27 Jan 2022 | 3,589 | 148,832 (3%) | 0% | 58.0 | 207,983 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 20,567 | 158,253 (3%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 4,725 | 34,779 (0%) | 0% | 0 | Common Stock | |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.80 per share. | 27 Jan 2022 | 1,466 | 15,613 (0%) | 0% | 57.8 | 84,735 | Common Stock |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 5,748 | 17,079 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 5,343 | 27,710 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.95 per share. | 27 Jan 2022 | 810 | 25,530 (0%) | 0% | 58.0 | 46,940 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.80 per share. | 27 Jan 2022 | 1,370 | 26,340 (0%) | 0% | 57.8 | 79,186 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 57.17 per share. | 03 Jan 2022 | 262 | 18,076 (0%) | 0% | 57.2 | 14,978 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 57.17 per share. | 03 Jan 2022 | 273 | 9,472 (0%) | 0% | 57.2 | 15,607 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 54.25 per share. | 20 Dec 2021 | 1,000 | 1,000 (0%) | 0% | 54.3 | 54,250 | Common Stock |
Christopher W. Haga | Director | Purchase of securities on an exchange or from another person at price $ 54.82 per share. | 10 Dec 2021 | 1,800 | 9,199 (0%) | 0% | 54.8 | 98,676 | Common Stock |
Laura M. Franklin | Director | Purchase of securities on an exchange or from another person at price $ 54.45 per share. | 03 Nov 2021 | 915 | 9,398 (0%) | 0% | 54.5 | 49,822 | Common Stock |
Casey Wold | Director | Grant, award, or other acquisition of securities at price $ 54.41 per share. | 01 Oct 2021 | 229 | 8,005 (0%) | 0% | 54.4 | 12,461 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 54.42 per share. | 01 Oct 2021 | 183 | 8,483 (0%) | 0% | 54.4 | 9,958 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 54.41 per share. | 01 Oct 2021 | 275 | 17,814 (0%) | 0% | 54.4 | 14,964 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 54.41 per share. | 01 Oct 2021 | 287 | 7,399 (0%) | 0% | 54.4 | 15,617 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 54.41 per share. | 01 Oct 2021 | 264 | 6,738 (0%) | 0% | 54.4 | 14,365 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 53.13 per share. | 27 Sep 2021 | 1,991 | 137,606 (2%) | 0% | 53.1 | 105,775 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 54.23 per share. | 27 Sep 2021 | 5,889 | 139,597 (2%) | 0% | 54.2 | 319,389 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.38 per share. | 07 Sep 2021 | 13,204 | 145,486 (2%) | 0% | 56.4 | 744,442 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 15,167 | 0 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.35 per share. | 07 Sep 2021 | 15,167 | 158,690 (3%) | 0% | 44.3 | 672,656 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.34 per share. | 27 Aug 2021 | 17,591 | 143,523 (2%) | 0% | 55.3 | 973,486 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 20,000 | 15,167 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.35 per share. | 27 Aug 2021 | 20,000 | 161,114 (3%) | 0% | 44.4 | 887,000 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Aug 2021 | 47 | 141,114 (2%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Purchase of securities on an exchange or from another person at price $ 52.93 per share. | 19 Aug 2021 | 500 | 8,300 (0%) | 0% | 52.9 | 26,467 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 54.30 per share. | 12 Aug 2021 | 1,000 | 17,539 (0%) | 0% | 54.3 | 54,304 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 54.30 per share. | 12 Aug 2021 | 1,000 | 17,539 (0%) | 0% | 54.3 | 54,304 | Common Stock |
Christopher W. Haga | Director | Purchase of securities on an exchange or from another person at price $ 54.38 per share. | 12 Aug 2021 | 1,000 | 1,000 (0%) | 0% | 54.4 | 54,384 | Common Stock |
Christopher W. Haga | Director | Purchase of securities on an exchange or from another person at price $ 53.86 per share. | 12 Aug 2021 | 1,000 | 1,000 (0%) | 0% | 53.9 | 53,860 | Common Stock |
Matthew M. Partridge | SR. VP, CFO & TREASURER | Purchase of securities on an exchange or from another person at price $ 54.75 per share. | 12 Aug 2021 | 1,000 | 11,331 (0%) | 0% | 54.8 | 54,750 | Common Stock |
Casey Wold | Director | Grant, award, or other acquisition of securities at price $ 54.40 per share. | 01 Jul 2021 | 229 | 7,776 (0%) | 0% | 54.4 | 12,457 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 54.40 per share. | 01 Jul 2021 | 183 | 7,800 (0%) | 0% | 54.4 | 9,955 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 54.40 per share. | 01 Jul 2021 | 254 | 16,539 (0%) | 0% | 54.4 | 13,817 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 54.40 per share. | 01 Jul 2021 | 287 | 7,112 (0%) | 0% | 54.4 | 15,612 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 54.40 per share. | 01 Jul 2021 | 264 | 6,474 (0%) | 0% | 54.4 | 14,361 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 50.95 per share. | 13 May 2021 | 1,000 | 16,285 (0%) | 0% | 51.0 | 50,954 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 52.60 per share. | 10 May 2021 | 1,000 | 13,285 (0%) | 0% | 52.6 | 52,598 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 50.42 per share. | 10 May 2021 | 2,000 | 15,285 (0%) | 0% | 50.4 | 100,850 | Common Stock |
Casey Wold | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 234 | 7,547 (0%) | 0% | 53.3 | 12,470 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 187 | 7,617 (0%) | 0% | 53.3 | 9,965 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 246 | 12,285 (0%) | 0% | 53.3 | 13,109 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 281 | 12,152 (0%) | 0% | 53.3 | 14,974 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 293 | 6,825 (0%) | 0% | 53.3 | 15,614 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 53.29 per share. | 01 Apr 2021 | 269 | 6,210 (0%) | 0% | 53.3 | 14,335 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 15 Mar 2021 | 3,541 | 29,457 (0%) | 0% | 39.9 | 141,180 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 3,541 | 9,000 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.10 per share. | 11 Mar 2021 | 4,365 | 140,501 (2%) | 0% | 56.1 | 244,877 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.35 per share. | 11 Mar 2021 | 5,000 | 144,866 (2%) | 0% | 44.4 | 221,750 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.85 per share. | 11 Mar 2021 | 10,083 | 148,831 (3%) | 0% | 45.9 | 462,306 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.10 per share. | 11 Mar 2021 | 8,965 | 139,866 (2%) | 0% | 56.1 | 502,937 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 5,000 | 35,167 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 10,083 | 0 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.24 per share. | 03 Mar 2021 | 8,894 | 137,224 (2%) | 0% | 54.2 | 482,411 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 15,000 | 10,083 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2021 | 10,000 | 40,167 | - | - | Employee Stock Option | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.07 per share. | 03 Mar 2021 | 13,476 | 138,748 (2%) | 0% | 55.1 | 742,123 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.85 per share. | 03 Mar 2021 | 15,000 | 152,224 (3%) | 0% | 45.9 | 687,750 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.35 per share. | 03 Mar 2021 | 10,000 | 146,118 (2%) | 0% | 44.4 | 443,500 | Common Stock |
Casey Wold | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 7,313 (0%) | 0% | 44.4 | 34,970 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 7,430 (0%) | 0% | 44.4 | 34,970 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 12,039 (0%) | 0% | 44.4 | 34,970 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 12,273 (0%) | 0% | 44.4 | 34,970 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 6,532 (0%) | 0% | 44.4 | 34,970 | Common Stock |
Matthew M. Partridge | SR. VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 4,101 | 10,332 (0%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 44.38 per share. | 10 Feb 2021 | 788 | 5,941 (0%) | 0% | 44.4 | 34,970 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 9,803 | 136,118 (2%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.68 per share. | 09 Feb 2021 | 2,222 | 126,315 (2%) | 0% | 45.7 | 101,501 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 9,128 | 128,537 (2%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 2,020 | 23,506 (0%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 2,900 | 25,916 (0%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.68 per share. | 09 Feb 2021 | 490 | 23,016 (0%) | 0% | 45.7 | 22,383 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 4,101 | 22,367 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.68 per share. | 09 Feb 2021 | 484 | 18,266 (0%) | 0% | 45.7 | 22,109 | Common Stock |
Steven Robert Greathouse | SVP & CHIEF INVESTMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 2,029 | 18,750 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Jan 2021 | 22,000 | 121,564 (2%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.01 per share. | 28 Jan 2021 | 2,155 | 119,409 (2%) | 0% | 43.0 | 92,687 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.01 per share. | 28 Jan 2021 | 719 | 21,486 (0%) | 0% | 43.0 | 30,924 | Common Stock |
Steven Robert Greathouse | SVP-INVESTMENTS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.01 per share. | 28 Jan 2021 | 806 | 16,721 (0%) | 0% | 43.0 | 34,666 | Common Stock |
Casey Wold | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 341 | 6,525 (0%) | 0% | 41.0 | 13,967 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 317 | 6,660 (0%) | 0% | 41.0 | 12,984 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 366 | 11,251 (0%) | 0% | 41.0 | 14,991 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 329 | 11,485 (0%) | 0% | 41.0 | 13,475 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 390 | 5,744 (0%) | 0% | 41.0 | 15,974 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 40.96 per share. | 04 Jan 2021 | 317 | 5,153 (0%) | 0% | 41.0 | 12,984 | Common Stock |
Matthew M. Partridge | SR. VP & CFO | Purchase of securities on an exchange or from another person at price $ 41.75 per share. | 14 Dec 2020 | 1,200 | 5,200 (0%) | 0% | 41.8 | 50,100 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 41.59 per share. | 11 Dec 2020 | 1,200 | 117,971 (2%) | 0% | 41.6 | 49,905 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 41.59 per share. | 11 Dec 2020 | 7,135 | 119,171 (2%) | 0% | 41.6 | 296,745 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 41.04 per share. | 11 Dec 2020 | 1,300 | 126,306 (2%) | 0% | 41.0 | 53,346 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 302 | 4,808 (0%) | 0% | 44.1 | 13,318 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 302 | 4,932 (0%) | 0% | 44.1 | 13,318 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 302 | 8,463 (0%) | 0% | 44.1 | 13,318 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 371 | 8,674 (0%) | 0% | 44.1 | 16,361 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 360 | 4,163 (0%) | 0% | 44.1 | 15,876 | Common Stock |
Matthew M. Partridge | SR. VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 44.10 per share. | 01 Oct 2020 | 348 | 3,760 (0%) | 0% | 44.1 | 15,347 | Common Stock |
Christopher W. Haga | Director | Purchase of securities on an exchange or from another person at price $ 43.74 per share. | 14 Sep 2020 | 1,200 | 1,200 (0%) | 0% | 43.7 | 52,489 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 40.25 per share. | 03 Aug 2020 | 500 | 7,691 (0%) | 0% | 40.2 | 20,124 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 40.35 per share. | 03 Aug 2020 | 1,000 | 7,191 (0%) | 0% | 40.4 | 40,352 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 40.97 per share. | 03 Aug 2020 | 414 | 8,161 (0%) | 0% | 41.0 | 16,961 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 40.50 per share. | 03 Aug 2020 | 56 | 7,747 (0%) | 0% | 40.5 | 2,268 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 288 | 4,506 (0%) | 0% | 41.6 | 11,983 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 312 | 4,630 (0%) | 0% | 41.6 | 12,982 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 312 | 6,191 (0%) | 0% | 41.6 | 12,982 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 324 | 8,303 (0%) | 0% | 41.6 | 13,481 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 312 | 3,803 (0%) | 0% | 41.6 | 12,982 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 41.61 per share. | 01 Jul 2020 | 312 | 3,412 (0%) | 0% | 41.6 | 12,982 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Jun 2020 | 134 | 127,606 (2%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 May 2020 | 100 | 127,740 (2%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 36.76 per share. | 14 May 2020 | 500 | 17,380 (0%) | 0% | 36.8 | 18,379 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 39.56 per share. | 12 May 2020 | 52 | 5,131 (0%) | 0% | 39.6 | 2,057 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 39.60 per share. | 12 May 2020 | 200 | 5,079 (0%) | 0% | 39.6 | 7,920 | Common Stock |
George R. Brokaw | Director | Purchase of securities on an exchange or from another person at price $ 39.65 per share. | 12 May 2020 | 748 | 5,879 (0%) | 0% | 39.6 | 29,658 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 441 | 4,218 (0%) | 0% | 46.4 | 20,457 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 344 | 4,318 (0%) | 0% | 46.4 | 15,957 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 377 | 4,803 (0%) | 0% | 46.4 | 17,488 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 420 | 7,979 (0%) | 0% | 46.4 | 19,483 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 463 | 3,491 (0%) | 0% | 46.4 | 21,477 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 01 Apr 2020 | 377 | 3,100 (0%) | 0% | 46.4 | 17,488 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 49.62 per share. | 12 Mar 2020 | 100 | 16,330 (0%) | 0% | 49.6 | 4,962 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 48.50 per share. | 12 Mar 2020 | 250 | 16,880 (0%) | 0% | 48.5 | 12,125 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 49.00 per share. | 12 Mar 2020 | 200 | 16,630 (0%) | 0% | 49 | 9,800 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 49.62 per share. | 12 Mar 2020 | 100 | 16,430 (0%) | 0% | 49.6 | 4,962 | Common Stock |
Steven Robert Greathouse | SVP-INVESTMENTS | Purchase of securities on an exchange or from another person at price $ 49.50 per share. | 12 Mar 2020 | 415 | 13,727 (0%) | 0% | 49.5 | 20,543 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 3,777 (0%) | 0% | 63.8 | 19,962 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2020 | 6,644 | 127,840 (2%) | 0% | 0 | Common Stock | |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 3,974 (0%) | 0% | 63.8 | 19,962 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 4,426 (0%) | 0% | 63.8 | 19,962 | Common Stock |
Mark Patten | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2020 | 2,156 | 34,308 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 7,559 (0%) | 0% | 63.8 | 19,962 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 3,028 (0%) | 0% | 63.8 | 19,962 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2020 | 1,940 | 16,230 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP-INVESTMENTS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2020 | 2,352 | 13,312 (0%) | 0% | 0 | Common Stock | |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 63.78 per share. | 24 Feb 2020 | 313 | 2,723 (0%) | 0% | 63.8 | 19,962 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.43 per share. | 11 Feb 2020 | 1,269 | 121,196 (2%) | 0% | 61.4 | 77,955 | Common Stock |
John P. Albright | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2020 | 5,214 | 122,465 (2%) | 0% | 0 | Common Stock | |
Mark Patten | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2020 | 2,250 | 32,694 (0%) | 0% | 0 | Common Stock | |
Mark Patten | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.43 per share. | 11 Feb 2020 | 542 | 32,152 (0%) | 0% | 61.4 | 33,295 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.43 per share. | 11 Feb 2020 | 541 | 14,290 (0%) | 0% | 61.4 | 33,234 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2020 | 2,250 | 14,831 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | SVP-INVESTMENTS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.43 per share. | 11 Feb 2020 | 542 | 10,960 (0%) | 0% | 61.4 | 33,295 | Common Stock |
Steven Robert Greathouse | SVP-INVESTMENTS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2020 | 2,250 | 11,502 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.92 per share. | 28 Jan 2020 | 1,534 | 117,251 (2%) | 0% | 64.9 | 99,587 | Common Stock |
Mark Patten | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.92 per share. | 28 Jan 2020 | 571 | 30,444 (0%) | 0% | 64.9 | 37,069 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.92 per share. | 28 Jan 2020 | 542 | 12,581 (0%) | 0% | 64.9 | 35,187 | Common Stock |
Steven Robert Greathouse | SVP-INVESTMENTS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.92 per share. | 28 Jan 2020 | 565 | 9,252 (0%) | 0% | 64.9 | 36,680 | Common Stock |
Casey R. Wold | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 303 | 3,464 (0%) | 0% | 61.0 | 18,474 | Common Stock |
Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 287 | 3,661 (0%) | 0% | 61.0 | 17,498 | Common Stock |
George R. Brokaw | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 336 | 4,189 (0%) | 0% | 61.0 | 20,486 | Common Stock |
Howard Serkin | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 336 | 7,246 (0%) | 0% | 61.0 | 20,486 | Common Stock |
Christopher W. Haga | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 385 | 2,715 (0%) | 0% | 61.0 | 23,473 | Common Stock |
R. Blakeslee Gable | Director | Grant, award, or other acquisition of securities at price $ 60.97 per share. | 02 Jan 2020 | 336 | 2,410 (0%) | 0% | 61.0 | 20,486 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 62.71 per share. | 12 Dec 2019 | 100 | 13,098 (0%) | 0% | 62.7 | 6,271 | Common Stock |
Daniel Earl Smith | SVP, GEN COUNSEL & CORP SECRET | Purchase of securities on an exchange or from another person at price $ 62.76 per share. | 12 Dec 2019 | 25 | 13,123 (0%) | 0% | 62.8 | 1,569 | Common Stock |
Steven Robert Greathouse | SVP-INVESTMENTS | Purchase of securities on an exchange or from another person at price $ 62.69 per share. | 12 Dec 2019 | 285 | 9,817 (0%) | 0% | 62.7 | 17,866 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 61.70 per share. | 05 Dec 2019 | 76 | 3,853 (0%) | 0% | 61.7 | 4,689 | Common Stock |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 188 | 3,161 (0%) | 0% | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 205 | 3,374 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 234 | 3,777 (0%) | 0% | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 249 | 6,910 (0%) | 0% | - | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 241 | 2,330 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2019 | 234 | 2,074 (0%) | 0% | - | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 209 | 2,973 (0%) | 0% | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 209 | 3,169 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 226 | 3,543 (0%) | 0% | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 235 | 6,661 (0%) | 0% | - | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 226 | 2,089 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2019 | 226 | 1,840 (0%) | 0% | - | Common Stock | |
John P. Albright | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Jun 2019 | 67 | 118,785 (2%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 59.92 per share. | 10 Jun 2019 | 5,000 | 31,015 (0%) | 0% | 59.9 | 299,623 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 59.10 per share. | 14 May 2019 | 500 | 3,317 (0%) | 0% | 59.1 | 29,550 | Common Stock |
Casey Wold | None | Purchase of securities on an exchange or from another person at price $ 59.12 per share. | 09 May 2019 | 500 | 2,764 (0%) | 0% | 59.1 | 29,560 | Common Stock |
John P. Albright | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Apr 2019 | 83 | 118,852 (2%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 278 | 2,264 (0%) | 0% | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 219 | 2,960 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 295 | 2,817 (0%) | 0% | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 295 | 6,426 (0%) | 0% | - | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 211 | 1,863 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2019 | 245 | 1,614 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Purchase of securities on an exchange or from another person at price $ 59.00 per share. | 07 Mar 2019 | 420 | 1,369 (0%) | 0% | 59 | 24,780 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 05 Mar 2019 | 200 | 2,022 (0%) | 0% | 60 | 12,000 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 59.64 per share. | 05 Mar 2019 | 500 | 2,522 (0%) | 0% | 59.6 | 29,820 | Common Stock |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 1,986 (0%) | 0% | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 2,741 (0%) | 0% | - | Common Stock | |
William L. Olivari | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 530 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 1,722 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 27 Feb 2019 | 100 | 1,822 (0%) | 0% | 60 | 6,000 | Common Stock |
Thomas P. Warlow | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 3,931 (0%) | 0% | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 6,131 (0%) | 0% | - | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 1,652 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2019 | 330 | 949 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Purchase of securities on an exchange or from another person at price $ 60.50 per share. | 20 Feb 2019 | 415 | 619 (0%) | 0% | 60.5 | 25,108 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 19 Feb 2019 | 8 | 1,392 (0%) | 0% | 60 | 480 | Common Stock |
Steven Robert Greathouse | Sr. VP-Investments | Purchase of securities on an exchange or from another person at price $ 60.60 per share. | 19 Feb 2019 | 98 | 9,485 (0%) | 0% | 60.6 | 5,939 | Common Stock |
Steven Robert Greathouse | Sr. VP-Investments | Purchase of securities on an exchange or from another person at price $ 61.00 per share. | 19 Feb 2019 | 47 | 9,532 (0%) | 0% | 61 | 2,867 | Common Stock |
Steven Robert Greathouse | Sr. VP-Investments | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 19 Feb 2019 | 1 | 9,387 (0%) | 0% | 60 | 60 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 60.03 per share. | 14 Feb 2019 | 38 | 1,384 (0%) | 0% | 60.0 | 2,281 | Common Stock |
George R. Brokaw | None | Purchase of securities on an exchange or from another person at price $ 60.11 per share. | 14 Feb 2019 | 500 | 1,346 (0%) | 0% | 60.1 | 30,055 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.52 per share. | 28 Jan 2019 | 1,526 | 118,935 (2%) | 0% | 59.5 | 90,828 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.52 per share. | 28 Jan 2019 | 622 | 36,015 (0%) | 0% | 59.5 | 37,021 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.52 per share. | 28 Jan 2019 | 611 | 13,071 (0%) | 0% | 59.5 | 36,367 | Common Stock |
Steven Robert Greathouse | Sr. VP-Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.52 per share. | 28 Jan 2019 | 613 | 9,386 (0%) | 0% | 59.5 | 36,486 | Common Stock |
John P. Albright | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 7,319 | 120,461 (2%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 2,283 | 36,637 (0%) | 0% | - | Common Stock | |
Daniel Earl Smith | Sr. VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 2,055 | 13,682 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | Sr. VP--Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2019 | 2,324 | 9,999 (0%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 333 | 1,656 (0%) | 0% | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 400 | 2,411 (0%) | 0% | - | Common Stock | |
George R. Brokaw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 346 | 846 (0%) | 0% | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 409 | 5,801 (0%) | 0% | - | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 447 | 1,322 (0%) | 0% | - | Common Stock | |
R. Blakeslee Gable | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2019 | 204 | 204 (0%) | 0% | - | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2018 | 248 | 1,323 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2018 | 224 | 2,011 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2018 | 313 | 5,392 (0%) | 0% | 0 | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2018 | 256 | 875 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | Sr. VP--Investments | Sale of securities on an exchange or to another person at price $ 64.25 per share. | 14 Aug 2018 | 2,800 | 7,675 (0%) | 0% | 64.3 | 179,900 | Common Stock |
Steven Robert Greathouse | Sr. VP--Investments | Sale of securities on an exchange or to another person at price $ 64.33 per share. | 07 Aug 2018 | 6 | 10,475 (0%) | 0% | 64.3 | 386 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.34 per share. | 31 Jul 2018 | 5,000 | 37,668 (0%) | 0% | 29.3 | 146,700 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.51 per share. | 31 Jul 2018 | 740 | 36,928 (0%) | 0% | 65.5 | 48,477 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2018 | 5,000 | 5,000 | - | - | Employee Stock Option (right to buy common stock) | |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2018 | 5,000 | 5,000 | - | - | Employee Stock Option (right to buy common stock) | |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 62.97 per share. | 31 Jul 2018 | 3,117 | 34,354 (0%) | 0% | 63.0 | 196,277 | Common Stock |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 64.94 per share. | 31 Jul 2018 | 300 | 37,471 (0%) | 0% | 64.9 | 19,482 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.91 per share. | 31 Jul 2018 | 740 | 37,771 (0%) | 0% | 62.9 | 46,553 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.34 per share. | 31 Jul 2018 | 5,000 | 38,511 (0%) | 0% | 29.3 | 146,700 | Common Stock |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 65.16 per share. | 31 Jul 2018 | 3,417 | 33,511 (0%) | 0% | 65.2 | 222,665 | Common Stock |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2018 | 203 | 1,075 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2018 | 227 | 1,787 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2018 | 284 | 5,079 (0%) | 0% | 0 | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2018 | 235 | 619 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 May 2018 | 82 | 113,142 (2%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2018 | 310 | 872 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2018 | 286 | 1,560 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2018 | 381 | 4,795 (0%) | 0% | 0 | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2018 | 294 | 384 (0%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 14 Feb 2018 | 820 | 32,668 (0%) | 0% | 64.3 | 52,685 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 14 Feb 2018 | 341 | 11,627 (0%) | 0% | 64.2 | 21,909 | Common Stock |
Steven Robert Greathouse | Sr. VP--Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 14 Feb 2018 | 410 | 10,481 (0%) | 0% | 64.3 | 26,343 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.19 per share. | 29 Jan 2018 | 1,700 | 113,224 (2%) | 0% | 66.2 | 112,523 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.19 per share. | 29 Jan 2018 | 729 | 32,788 (0%) | 0% | 60.2 | 43,879 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.19 per share. | 29 Jan 2018 | 498 | 11,895 (0%) | 0% | 66.2 | 32,963 | Common Stock |
Steven Robert Greathouse | Sr. VP--Investments | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.19 per share. | 29 Jan 2018 | 727 | 10,891 (0%) | 0% | 60.2 | 43,758 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.98 per share. | 24 Jan 2018 | 628 | 108,823 (1%) | 0% | 67.0 | 42,063 | Common Stock |
John P. Albright | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 6,101 | 114,924 (2%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 1,903 | 33,517 (0%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | Sr. VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 1,800 | 12,393 (0%) | 0% | 0 | Common Stock | |
Steven Robert Greathouse | Sr. VP--Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2018 | 1,808 | 11,618 (0%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2018 | 157 | 562 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2018 | 157 | 1,274 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2018 | 157 | 4,414 (0%) | 0% | 0 | Common Stock | |
Christopher Haga | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2018 | 90 | 90 (0%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.49 per share. | 22 Dec 2017 | 820 | 31,614 (0%) | 0% | 62.5 | 51,242 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.49 per share. | 22 Dec 2017 | 341 | 10,593 (0%) | 0% | 62.5 | 21,309 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 62.87 per share. | 15 Dec 2017 | 1,453 | 109,451 (1%) | 0% | 62.9 | 91,346 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.00 per share. | 12 Dec 2017 | 547 | 110,904 (1%) | 0% | 63 | 34,461 | Common Stock |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 166 | 405 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 166 | 1,117 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2017 | 166 | 4,257 (0%) | 0% | 0 | Common Stock | |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2017 | 2,000 | 2,000 | - | - | Employee Stock Option (right to buy common stock) | |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2017 | 2,000 | 0 | - | - | Employee Stock Option (right to buy common stock) | |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 54.92 per share. | 29 Aug 2017 | 1,320 | 32,434 (0%) | 0% | 54.9 | 72,492 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.64 per share. | 29 Aug 2017 | 198 | 33,754 (0%) | 0% | 54.6 | 10,819 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.95 per share. | 29 Aug 2017 | 2,000 | 33,952 (0%) | 0% | 35.0 | 69,900 | Common Stock |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 54.84 per share. | 29 Aug 2017 | 1,320 | 31,952 (0%) | 0% | 54.8 | 72,394 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.73 per share. | 29 Aug 2017 | 197 | 33,272 (0%) | 0% | 54.7 | 10,782 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.95 per share. | 29 Aug 2017 | 2,000 | 33,469 (0%) | 0% | 35.0 | 69,900 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.95 per share. | 22 Aug 2017 | 2,000 | 34,997 (0%) | 0% | 35.0 | 69,900 | Common Stock |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 53.78 per share. | 22 Aug 2017 | 2,640 | 32,169 (0%) | 0% | 53.8 | 141,968 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.09 per share. | 22 Aug 2017 | 188 | 34,809 (0%) | 0% | 54.1 | 10,169 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.95 per share. | 22 Aug 2017 | 2,000 | 32,707 (0%) | 0% | 35.0 | 69,900 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.46 per share. | 22 Aug 2017 | 194 | 32,513 (0%) | 0% | 54.5 | 10,565 | Common Stock |
Mark Patten | Sr. VP & CFO | Sale of securities on an exchange or to another person at price $ 53.95 per share. | 22 Aug 2017 | 1,320 | 31,193 (0%) | 0% | 53.9 | 71,211 | Common Stock |
Mark Patten | Sr. VP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.95 per share. | 22 Aug 2017 | 2,000 | 33,193 (0%) | 0% | 35.0 | 69,900 | Common Stock |
Mark Patten | Sr. VP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.25 per share. | 22 Aug 2017 | 196 | 32,997 (0%) | 0% | 53.3 | 10,437 | Common Stock |
John P. Albright | President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2017 | 32,000 | 111,451 (1%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2017 | 175 | 239 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2017 | 175 | 951 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2017 | 175 | 4,091 (0%) | 0% | 0 | Common Stock | |
Casey Wold | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 64 | 64 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 186 | 776 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2017 | 186 | 3,916 (0%) | 0% | 0 | Common Stock | |
Laura M. Franklin | None | Purchase of securities on an exchange or from another person at price $ 51.50 per share. | 15 Mar 2017 | 350 | 590 (0%) | 0% | 51.5 | 18,025 | Common Stock |
William L. Olivari | None | Purchase of securities on an exchange or from another person at price $ 52.00 per share. | 15 Mar 2017 | 500 | 5,500 (0%) | 0% | 52 | 26,000 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Purchase of securities on an exchange or from another person at price $ 50.40 per share. | 09 Mar 2017 | 100 | 10,934 (0%) | 0% | 50.4 | 5,040 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Purchase of securities on an exchange or from another person at price $ 50.74 per share. | 09 Mar 2017 | 125 | 10,834 (0%) | 0% | 50.7 | 6,343 | Common Stock |
Daniel Earl Smith | Sr. VP & General Counsel | Purchase of securities on an exchange or from another person at price $ 50.75 per share. | 09 Mar 2017 | 75 | 10,709 (0%) | 0% | 50.7 | 3,806 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 51.71 per share. | 08 Mar 2017 | 1,500 | 144,451 (2%) | 0% | 51.7 | 77,562 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 50.45 per share. | 08 Mar 2017 | 1,000 | 143,451 (2%) | 0% | 50.5 | 50,453 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.16 per share. | 22 Feb 2017 | 209 | 148,242 (2%) | 0% | 54.2 | 11,320 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.28 per share. | 22 Feb 2017 | 2,291 | 145,951 (2%) | 0% | 54.3 | 124,359 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.48 per share. | 08 Feb 2017 | 2,500 | 148,451 (2%) | 0% | 53.5 | 133,710 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.11 per share. | 30 Jan 2017 | 547 | 150,951 (2%) | 0% | 55.1 | 30,145 | Common Stock |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.11 per share. | 30 Jan 2017 | 729 | 151,498 (2%) | 0% | 55.1 | 40,175 | Common Stock |
Mark Patten | Sr. VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 2,000 | 30,707 (0%) | 0% | 0 | Common Stock | |
Daniel Earl Smith | Sr. VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2017 | 2,000 | 10,634 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2017 | 4,651 | 154,727 (2%) | 0% | 0 | Common Stock | |
John P. Albright | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.46 per share. | 23 Jan 2017 | 649 | 150,076 (2%) | 0% | 54.5 | 35,345 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.87 per share. | 23 Jan 2017 | 1,000 | 152,227 (2%) | 0% | 54.9 | 54,872 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.62 per share. | 23 Jan 2017 | 1,500 | 153,227 (2%) | 0% | 55.6 | 83,427 | Common Stock |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.51 per share. | 11 Jan 2017 | 2,500 | 150,725 (2%) | 0% | 55.5 | 138,769 | Common Stock |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2017 | 187 | 240 (0%) | 0% | 0 | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2017 | 187 | 3,730 (0%) | 0% | 0 | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2016 | 1,250 | 153,225 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2016 | 1,250 | 154,475 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Dec 2016 | 1,150 | 155,725 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Dec 2016 | 1,350 | 156,875 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2016 | 55 | 158,225 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Nov 2016 | 1,300 | 158,280 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Nov 2016 | 1,200 | 159,580 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Nov 2016 | 2,500 | 160,780 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Nov 2016 | 1,531 | 164,249 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 02 Nov 2016 | 969 | 163,280 | - | - | Common Stock | |
William L. Olivari | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 27 Oct 2016 | 500 | 5,000 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Oct 2016 | 2,000 | 165,780 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 19 Oct 2016 | 500 | 167,780 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Oct 2016 | 1,299 | 168,280 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 05 Oct 2016 | 1,201 | 169,579 | - | - | Common Stock | |
Laura M. Franklin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2016 | 53 | 53 | - | - | Common Stock | |
Howard Serkin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2016 | 195 | 3,543 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Sep 2016 | 1,700 | 171,580 | - | - | Common Stock | |
John P. Albright | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 21 Sep 2016 | 800 | 170,780 | - | - | Common Stock |